Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Anosmia × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 420 Neoplasms, Plasma Cell 95 Lymphoma 79 Lymphoma, Non-Hodgkin 68 Myelodysplastic Syndromes 67 Leukemia, Lymphocytic, Chronic, B-Cell 66 Leukemia 64 Precursor Cell Lymphoblastic Leukemia-Lymphoma 62 Leukemia, Myeloid, Acute 62 Hodgkin Disease 59 Recurrence 57 Lymphoma, Mantle-Cell 48 Lymphoma, Large B-Cell, Diffuse 48 Lymphoma, Follicular 42 Myeloproliferative Disorders 40 Lymphoma, B-Cell, Marginal Zone 39 Burkitt Lymphoma 39 Primary Myelofibrosis 36 Neoplasms 36 Lymphoma, Large-Cell, Immunoblastic 35 Lymphoma, T-Cell, Cutaneous 30 Leukemia, Myelomonocytic, Chronic 30 Sezary Syndrome 28 Mycosis Fungoides 28 Leukemia, Myeloid, Chronic-Phase 28 Leukemia, Myeloid, Accelerated Phase 28 Congenital Abnormalities 28 Leukemia, Hairy Cell 26 Blast Crisis 26 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 24

Interventions

Surveys and Questionnaires 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04716153 2026-01-20

RE-NEZ-SENS

University Hospital, Montpellier

Phase NA Terminated

LymphoidPlasma cell

Anosmia, Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡